Delayed Enhancement of Subendocardial Infarcted Myocardium with Gadobenate Dimeglumine: A Paradoxical Effect—Is a Double Dose Too Much?
2006; Radiological Society of North America; Volume: 240; Issue: 3 Linguagem: Inglês
10.1148/radiol.2403051674
ISSN1527-1315
AutoresFrancesco Sardanelli, Matteo Quarenghi,
Tópico(s)Lanthanide and Transition Metal Complexes
ResumoHomeRadiologyVol. 240, No. 3 PreviousNext CommunicationsLetters to the EditorDelayed Enhancement of Subendocardial Infarcted Myocardium with Gadobenate Dimeglumine: A Paradoxical Effect—Is a Double Dose Too Much?Francesco Sardanelli, Matteo QuarenghiFrancesco Sardanelli, Matteo QuarenghiAuthor AffiliationsUniversity of Milan School of Medicine, Department of Medical and Surgical Sciences, Radiology Unit, IRCCS, Policlinico San Donato, Via Morandi 30, 20097 San Donato Milanese, Milan, Italy e-mail: [email protected]Francesco SardanelliMatteo QuarenghiPublished Online:Sep 1 2006https://doi.org/10.1148/radiol.2403051674MoreSectionsFull textPDF ToolsImage ViewerAdd to favoritesCiteTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinked In References1 Schlosser T, Hunold P, Herborn CU, et al. Myocardial infarct: depiction with contrast-enhanced MR imaging—comparison of gadopentetate and gadobenate. Radiology 2005; 236: 1041–1046. Link, Google Scholar2 Cavagna FM, Maggioni F, Castelli PM, et al. Gadolinium chelates with weak binding to serum proteins: a new class of high-efficiency, general purpose contrast agents for magnetic resonance imaging. Invest Radiol 1997; 32: 780–796. Crossref, Medline, Google Scholar3 Kirchin MA, Pirovano G, Spinazzi A. Gadobenate dimeglumine (Gd-BOPTA): an overview. Invest Radiol 1998; 33: 798–809. Crossref, Medline, Google Scholar4 Knopp MV, Runge VM, Essig M, et al. Primary and secondary brain tumors at MR imaging: bicentric intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine. Radiology 2004; 230: 55–64. Link, Google Scholar5 Knopp MV, Giesel FL, von Tengg-Kobligk H, et al. Contrast-enhanced MR angiography of the run-off vasculature: intraindividual comparison of gadobenate dimeglumine with gadopentetate dimeglumine. J Magn Reson Imaging 2003; 17: 694–702. Crossref, Medline, Google Scholar6 Pediconi F, Catalano C, Occhiato R, et al. Breast lesion detection and characterization at contrast-enhanced MR mammography: gadobenate dimeglumine versus gadopentetate dimeglumine. Radiology 2005; 237: 45–56. Link, Google Scholar7 Schneider G, Maas R, Shultze Kool L, et al. Low-dose gadobenate dimeglumine versus standard dose gadopentetate dimeglumine for contrast-enhanced magnetic resonance imaging of the liver: an intra-individual cross-over comparison. Invest Radiol 2003; 38: 85–94. Crossref, Medline, Google Scholar8 Völk M, Strotzer M, Lenhart M, et al. Renal time-resolved MR angiography: quantitative comparison of gadobenate dimeglumine and gadopentetate dimeglumine with different doses. Radiology 2001; 220: 484–488. Link, Google Scholar9 Prokop M, Schneider G, Vanzulli A, et al. Contrast-enhanced MR angiography of the renal arteries: blinded multicenter crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine. Radiology 2005; 234: 399–408. Link, Google Scholar10 Sardanelli F, Iozzelli A, Fausto A, Carriero A, Kirchin MA. Gadobenate dimeglumine-enhanced MR imaging breast vascular maps: association between invasive cancer and ipsilateral increased vascularity. Radiology 2005; 235: 791–797. Link, Google Scholar11 Huber A, Schonberg SO, Spannagl B, Rieber J, Klauss V, Reiser MF. Determining myocardial viability in myocardial infarct: comparison of single and multislice MRI techniques with TurboFlash and TrueFISP sequences [in German]. Radiologe 2004; 44: 146–151. Crossref, Medline, Google Scholar12 Schneider G, Saedi D, Massmann A, et al. MultiHance in cardiac magnetic resonance imaging. Eur Radiol 2004; 14(suppl 7): O71–O79. Crossref, Medline, Google ScholarArticle HistoryPublished in print: 2006 FiguresReferencesRelatedDetailsCited ByAssessment of nonischemic fibrosis in hypertrophic cardiomyopathy: Comparison of gadopentetate dimeglumine and gadobenate dimeglumine for enhanced cardiovascular magnetic resonance imagingAndreRudolph, Florianvon Knobelsdorff-Brenkenhoff, RalfWassmuth, MarcelProthmann, WolfgangUtz, JeanetteSchulz-Menger2014 | Journal of Magnetic Resonance Imaging, Vol. 39, No. 5Ultra low-dose of gadobenate dimeglumine for late gadolinium enhancement (LGE) imaging in acute myocardial infarction: A feasibility studyNicolaGalea, MarcoFrancone, FulvioZaccagna, FedericaCiolina, DavidCannata, EmanuelaAlgeri, LucianoAgati, CarloCatalano, IacopoCarbone2014 | European Journal of Radiology, Vol. 83, No. 12Optimizing dose and administration regimen of a high-relaxivity contrast agent for myocardial MRI late gadolinium enhancementFrancescoSecchi, GiovanniDi Leo, Giacomo D.E.Papini, FrancescaGiacomazzi, MarisaDi Donato, FrancescoSardanelli2011 | European Journal of Radiology, Vol. 80, No. 1Myocardial delayed enhancement using a single dose (0.1 mmol/kg) of gadobenate dimeglumine: contrast resolution versus intraventricular blood and viable myocardiumG.D.E.Papini, S.Tritella, F.Secchi, A.Aliprandi, G.Di Leo, F.Sardanelli2010 | La radiologia medica, Vol. 115, No. 5Gd-BOPTA for assessment of myocardial viability on MRI: changes of T1 value and their impact on delayed enhancementGabriele A.Krombach, ChristaHahnen, Klaus-PeterLodemann, NilsKrämer, FelixSchoth, MirjaNeizel, JanBoeringer, Rolf W.Günther, MalteKelm, HaraldKühl2009 | European Radiology, Vol. 19, No. 9Left Ventricular Infarct Size Assessed With 0.1 mmol/kg of Gadobenate Dimeglumine Correlates With That Assessed With 0.2 mmol/kg of Gadopentetate DimeglumineMonraveeTumkosit, ChirapaPuntawangkoon, Tim M.Morgan, Hollins P.Clark, Craig A.Hamilton, William O.Ntim, Paige B.Clark, W. GregoryHundley2009 | Journal of Computer Assisted Tomography, Vol. 33, No. 3Low Dose Gadobenate Dimeglumine for Imaging Of Chronic Myocardial Infarction in Comparison With Standard Dose Gadopentetate DimeglumineKerstin U.Bauner, Maximilian F.Reiser, Armin M.Huber2009 | Investigative Radiology, Vol. 44, No. 2Gadobenate Dimeglumine as a Contrast Agent for Dynamic Breast Magnetic Resonance ImagingFrancescoSardanelli, AlfonsoFausto, AnastassiaEsseridou, Giovanni DiLeo, Miles A.Kirchin2008 | Investigative Radiology, Vol. 43, No. 4Recommended Articles Cardiac MR Imaging in Acute Coronary Syndrome: Application and Image InterpretationRadiology2016Volume: 282Issue: 1pp. 17-32Delayed Gadolinium-enhanced MR Imaging of Cartilage: A Comparative Analysis of Different Gadolinium-based Contrast Agents in an ex Vivo Porcine ModelRadiology2016Volume: 282Issue: 3pp. 734-742Ischemic Heart Disease: Noninvasive Imaging Techniques and FindingsRadioGraphics2021Volume: 41Issue: 4pp. 990-1021Acute versus Chronic Myocardial Infarction: Diagnostic Accuracy of Quantitative Native T1 and T2 Mapping versus Assessment of Edema on Standard T2-weighted Cardiovascular MR Images for DifferentiationRadiology2017Volume: 285Issue: 1pp. 83-91Cardiac MRI to Visualize Myocardial Damage after ST-Segment Elevation Myocardial Infarction: A Review of Its Histologic ValidationRadiology2021Volume: 301Issue: 1pp. 4-18See More RSNA Education Exhibits Acute Myocardial Injury: Beyond Atherosclerotic Plaque DisruptionDigital Posters2020Practical Approaches and Updated Topics in Gadoxetate-Enhanced MR Imaging of the Liver: What the Radiologists Should KnowDigital Posters2019Cardiac MR Mapping: Diagnostic Strategy in Clinical PracticeDigital Posters2018 RSNA Case Collection Hibernating MyocardiumRSNA Case Collection2020Cardiac fibromaRSNA Case Collection2020Acute myocardial InfarctionRSNA Case Collection2021 Vol. 240, No. 3 Metrics Altmetric Score PDF download
Referência(s)